Gilead Sciences (GILD) 70.01 $GILD Most active

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 70.01 $GILD

Most active Nasdaq-traded stocks
AP - 46 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Final Glance: Biotechnology companies
AP - 47 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:

Pipeline Update from Idenix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 20 mins ago
Idenix's nucleotide polymerase inhibitor candidate, IDX21437, showed potent antiviral activity in patients suffering from hepatitis C virus (HCV) infection.

Watch for Gilead Sciences to Potentially Rebound After Falling 3.07% Yesterday
Comtex SmarTrend(R) - 2 hrs 34 mins ago
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $69.28 to a high of $71.71. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $70.72 on volume of 25.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Nike Sprints Higher as the Dow Dips Again
Dan Carroll, The Motley Fool - Motley Fool - Tue Apr 08, 1:39PM CDT
While stocks have bounced back from yesterday's big losses as the markets approach earnings season again, one index is heading down again. As of 2:35 p.m. EDT, the Dow Jones Industrial Average was just under breakeven, with blue-chip member stocks...

Midday Glance: Biotechnology companies
AP - Tue Apr 08, 12:16PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

FDA Target Date for Gilead's HCV Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 10:30AM CDT
Gilead is looking to bring a fixed-dose combination of Sovaldi and ledipasvir into the market for treating HCV.

Healthcare Investors Suffering Losses While Drug-Pricing War Rages
at The Street - Tue Apr 08, 10:23AM CDT
The latest salvo was lobbed Tuesday by pharmacy benefits manager Express Scripts against Gilead Sciences and its $1,000-per-day hepatitis C pill Sovaldi. Express Scripts says the U.S. healthcare system can't afford Sovaldi so it wants to form a...

Jim Cramer's Stop Trading: GILD ESRX
at The Street - Tue Apr 08, 9:59AM CDT
In the battle between Gilead and Express Scripts over the cost of hepatitis C pill Sovaldi, Gilead wins, Cramer asserts.

Early Glance: Biotechnology companies
AP - Tue Apr 08, 9:43AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Encouraging Results from Pfizer's Palbociclib - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:40AM CDT
Pfizer announced positive detailed results from the phase II study on palbociclib.

Watch for Shares of Gilead Sciences (GILD) to Approach Support at $69.22
Comtex SmarTrend(R) - Tue Apr 08, 9:02AM CDT
Gilead Sciences (NASDAQ:GILD) has opened bearishly below the pivot of $72.23 today and has reached the first level of support at $70.72. Analysts will be watching for a cross of the next downside pivot targets of $69.22 and $66.21.

MannKind vs. Idenix: Better Biotech Buy
David Williamson, The Motley Fool - Motley Fool - Mon Apr 07, 6:17PM CDT
In this video after a big day in the biotech sector, Motley Fool health-care analyst David Williamson takes investors through today's big winner and loser. Idenix is the winner for the day, up 10% after posting solid results in a...

A $1 Trillion Drug Market?
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 07, 5:30PM CDT
At the Barclays Global Healthcare Conference 2014 last month, Christopher Anzalone, president and CEO of Arrowhead Research   put up a slide suggesting that its hepatitis B drug would treat a $1 trillion market "even under conservative pricing...

Tweet of the Week: Big Biotech Dominates Industry Gains
Brian Orelli and Max Macaluso, The Motley Fool - Motley Fool - Mon Apr 07, 4:25PM CDT
This week's tweet comes from Bruce Booth (@LifeSciVC), who points out analysts at Bernstein concluded that just six companies contributed to 77% of the increase in value of the biotech sector over the past three years. There's no doubt that Amgen...

Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Apr 07, 12:21PM CDT
Momentum stocks may soon bounce back, but for now earnings hold the key.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hard Rock Casino Tejon Commences $725M Expansion Project

Updated Category News Views 2

Ground Broken for Hard Rock Casino Tejon's Ambitious Expansion Who’s got a shovel ready? Hard Rock Casino Tejon does, kicking off a $725 million expansion that's turning heads all the way from Bakersfield to Los Angeles. Let's get something straight: this ain’t just another face-lift. We’re talking about a full-on transformation of the place into a plush resort...

Continue Reading
Dean Tucci Fights a $43 Million CFPB Penalty

Updated Category News Views 4

Another Day, Another Court Battle Well, folks, if you thought corporate America was the only place where the numbers get wild, let me introduce you to Dean Tucci's latest legal nightmare. The man's up against a $43 million judgment from the Consumer Financial Protection Bureau (CFPB). For a business that did $2 million over three years? Yeah, you heard that right—sounds...

Continue Reading
Ransomware Hits The Money Store, Data at Risk

Updated Category News Views 0

Ransomware in the Mortgage Sector Feels like data breaches are the new rainy day—unwelcome and unavoidable. This time, the storm hit MLD Mortgage Inc., otherwise known as The Money Store. You’d think that with a name like that, they'd keep a tight grip on their data. But nope, they've got a mess on their hands, and Edelson Lechtzin LLP is on the case, poking into this...

Continue Reading
Blokees Unveils 900+ Toys at China Expo, Eyes Growth

Updated Category News Views 0

Toy Titans and Strategic Prowess Swinging into Shanghai with the enthusiasm of a kid in a candy store, Blokees laid out a dazzling array of over 900 products at the 2026 China Toy Expo. Showing off its model kits and BLOKEES WHEELS, it's clear the company's firing on all cylinders, hell-bent on driving competitiveness like a rookie trying to prove their worth in a...

Continue Reading
MIAX Launches New Fertilizer Futures Amid Market Fluctuations

Updated Category News Views 4

MIAX Sets Sights on Fertilizer Futures Out of the blue, we’ve got MIAX—one of the major players in financial markets—tossing their hat into the ring with fertilizer futures. They aren’t just playing around; they’ve launched four new physically-settled fertilizer futures contracts. You might wonder, why fertilizers? Hang tight, I'll tell you. MIAX is tapping into...

Continue Reading
Monkee's of Loudoun Opens to Cheers and Elegance

Updated Category News Views 3

Bringing Southern Charm to Loudoun We've all seen those places where people parade in with snooty airs and pricetags that could feed a family for a week, but this one feels different. Monkee’s of Loudoun isn’t just rolling in the racks of high fashion — it’s bringing the allure of the South with a sprinkle of luxury and empathy. This franchise is no amateur,...

Continue Reading
Bolt Teams with NVIDIA for Europe AV Expansion

Updated Category News Views 6

Racing Towards an Autonomous Future Well, hold onto your seats because the European roads will soon witness one hell of a technological trip—with an autonomous twist. Bolt, in cahoots with NVIDIA and Lucid, is plotting to roll out a massive fleet of autonomous vehicles just gearing up to hit the streets. The project's kicking off in Madrid in 2027 and aims to sprinkle...

Continue Reading
Luxury Travelers Prefer Private Jets for Time Savings

Updated Category News Views 6

The Evolving Landscape of Luxury Travel Time, it seems, is the new currency in the realm of luxury travel. Forget plush hotel suites or exclusive first-class cabins—the new game is all about maximizing your moments at the destination rather than en route. 2026 showed us vivid snapshots of this trend, courtesy of SELECT Private Jets by Internova, revealing how...

Continue Reading
Factors Driving Up Car Window Tinting Costs Explained

Updated Category News Views 2

Decoding the Dollars Behind Car Window Tinting When you think about car upgrades, window tinting might not scream excitement. But, my friends, it ain't all about the aesthetics. Dive into the nuts and bolts of cost with insights from Francis Alegre, a seasoned pro from StayShine Detailing in Voorhees, New Jersey, featured in HelloNation's rundown. The Glass Mass Factor...

Continue Reading
TrendAI and NVIDIA: Bridging AI & Data Sovereignty

Updated Category News Views 7

Sovereign Control Meets AI Innovation Ever been in a position where holding onto control felt as crucial as making a profit? Welcome to the newest frontier in AI security where TrendAI™ and NVIDIA are shaking hands. This ain't just some tech kumbaya—it’s a pivotal meet-up for firms keen on iron-clad control over their data gears while pushing AI-driven security into...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Four-Star Hotel to Redefine Luxury in Downtown Area

Updated Category News Views 57

Exciting New Luxury Hotel Coming to Downtown Pacific Hospitality Group (PHG), in partnership with Berger Holdings and JWG Investments, has announced a thrilling new development. They’re set to break ground on an exceptional independent lifestyle hotel that's part of the esteemed Meritage Collection. This venture represents a significant step forward for luxury...

Continue Reading
Batteries Plus to Launch Franchise Stores across Hawaii

Updated Category News Views 194

Batteries Plus Expands to Hawaii with New Franchise Initiative Batteries Plus, a prominent specialty battery retailer, is making significant strides by entering Hawaii with a new franchise deal. This move showcases the company's commitment to enhancing its national presence while responding to the growing demand for reliable battery solutions. Four-Unit Deal and...

Continue Reading
Baird Adjusts Zions Bancorp Price Target Amid Strong Earnings

Updated Category News Views 45

Zions Bancorp's Price Target Increased by Baird Baird has recently raised the price target for Zions Bancorp (NASDAQ: ZION) from $52.00 to $55.00, reflecting optimism about the company’s strong third-quarter performance. Despite this adjustment, the firm has opted to maintain a Neutral rating on the stock. Strong Q3 Performance Indicators The upgrade stems from Zions...

Continue Reading
AUTOCRYPT Unveils Pioneering Post-Quantum PKI for Automotive Sector

Updated Category News Views 216

AUTOCRYPT Unveils Revolutionary PKI Solution for Automotive Security Seoul-based AUTOCRYPT has recently announced an exciting milestone in automotive cybersecurity with the introduction of its new Public Key Infrastructure (PKI), known as AutoCrypt PKI-Vehicles. This cutting-edge technology is designed to support ML-DSA, a post-quantum digital signature algorithm that...

Continue Reading
Sweetgreen's Nathaniel Ru Executes Major Share Transactions

Updated Category News Views 94

Nathaniel Ru's Major Transaction at Sweetgreen Sweetgreen, Inc. (NYSE: SG) has recently disclosed a significant transaction involving their Chief Brand Officer, Nathaniel Ru. According to the latest filings, he sold 38,295 shares of Class A Common Stock, totaling over $1.3 million. Details of the Sale This sale was executed at a weighted average price of $35.08 per share,...

Continue Reading